D C Tsitoura1, R L Blumenthal, G Berry, R H Dekruyff, D T Umetsu. 1. Department of Pediatrics, Divisions of Allergy and Clinical Immunology, Immunology and Transplantation Biology, Stanford University Medical Center, Stanford, CA 94305-5208, USA.
Abstract
BACKGROUND: Aeroallergens continuously enter the respiratory tract of atopic individuals and provoke the development of asthma characterized by airway hyperreactivity (AHR) and inflammation. By contrast, nonatopic individuals are exposed to the same aeroallergens, but airway inflammation does not develop. However, the mechanisms that prevent allergen-induced respiratory diseases in nonatopic subjects are poorly characterized. OBJECTIVE: In this study we compared the role of allergen-specific T-cell tolerance and immune deviation in conferring protection against the development of allergen-induced AHR. METHODS: We exposed mice to intranasal ovalbumin (OVA) to induce T-cell tolerance and examined its effects on the subsequent development of AHR and inflammation. RESULTS: We demonstrated that exposure of mice to intranasal OVA resulted in peripheral CD4(+) T-cell unresponsiveness that very efficiently prevented not only the development of AHR but also greatly inhibited airway inflammation and OVA-specific IgE production. The induction of peripheral T-cell tolerance and protection against AHR were not dependent on the presence of IFN-gamma or IL-4. The development of AHR was also prevented by an OVA-specific T(H)1-biased immune response induced by inhalation of OVA in the presence of IL-12. However, the OVA-specific T(H)1 response was associated with a significant degree of pulmonary inflammation. CONCLUSION: These results indicate that both allergen-specific T-cell tolerance and T(H)1-biased immune deviation prevent the development of AHR, but T(H)1 responses are associated with significantly greater inflammation in the lung than is associated with T-cell unresponsiveness. Therefore CD4(+) T-cell unresponsiveness critically regulates immune responses to aeroallergens and protects against the development of allergic disease and asthma.
BACKGROUND: Aeroallergens continuously enter the respiratory tract of atopic individuals and provoke the development of asthma characterized by airway hyperreactivity (AHR) and inflammation. By contrast, nonatopic individuals are exposed to the same aeroallergens, but airway inflammation does not develop. However, the mechanisms that prevent allergen-induced respiratory diseases in nonatopic subjects are poorly characterized. OBJECTIVE: In this study we compared the role of allergen-specific T-cell tolerance and immune deviation in conferring protection against the development of allergen-induced AHR. METHODS: We exposed mice to intranasal ovalbumin (OVA) to induce T-cell tolerance and examined its effects on the subsequent development of AHR and inflammation. RESULTS: We demonstrated that exposure of mice to intranasal OVA resulted in peripheral CD4(+) T-cell unresponsiveness that very efficiently prevented not only the development of AHR but also greatly inhibited airway inflammation and OVA-specific IgE production. The induction of peripheral T-cell tolerance and protection against AHR were not dependent on the presence of IFN-gamma or IL-4. The development of AHR was also prevented by an OVA-specific T(H)1-biased immune response induced by inhalation of OVA in the presence of IL-12. However, the OVA-specific T(H)1 response was associated with a significant degree of pulmonary inflammation. CONCLUSION: These results indicate that both allergen-specific T-cell tolerance and T(H)1-biased immune deviation prevent the development of AHR, but T(H)1 responses are associated with significantly greater inflammation in the lung than is associated with T-cell unresponsiveness. Therefore CD4(+) T-cell unresponsiveness critically regulates immune responses to aeroallergens and protects against the development of allergic disease and asthma.
Authors: Mairi C Noverr; Nicole R Falkowski; Rod A McDonald; Andrew N McKenzie; Gary B Huffnagle Journal: Infect Immun Date: 2005-01 Impact factor: 3.441
Authors: Christopher G McKnight; Joseph A Jude; Zhenqi Zhu; Reynold A Panettieri; Fred D Finkelman Journal: Am J Respir Cell Mol Biol Date: 2017-12 Impact factor: 6.914
Authors: Paul C Porter; Tianshu Yang; Amber Luong; George L Delclos; Stuart L Abramson; Farrah Kheradmand; David B Corry Journal: Biochim Biophys Acta Date: 2011-06-25
Authors: Anurag Singh; Roger S Thrall; Linda A Guernsey; William F Carson; Eric R Secor; Robert E Cone; Thiruchandurai V Rajan; Craig M Schramm Journal: Immunol Cell Biol Date: 2008-05-06 Impact factor: 5.126
Authors: Jasmine I Caulfield; Michael J Caruso; Kerry C Michael; Rebecca A Bourne; Nicole R Chirichella; Laura C Klein; Timothy Craig; Robert H Bonneau; Avery August; Sonia A Cavigelli Journal: Behav Brain Res Date: 2017-03-08 Impact factor: 3.332